Skip to main content
ScienceEmergingMedium
5.2

AI-discovered drug cuts biological age in pulmonary fibrosis trial

An AI-discovered medicine reduced biological age markers in 42 pulmonary fibrosis patients, per a trial. Details on mechanism, control group, and statistical significance are unclear. If confirmed, this could signal a novel therapeutic approach for aging-related diseases.

InfoMoney2 days agoCredibility 47%View source

Score Breakdown

Mosaic Score5.2
Confidence0.1
Significance0.5
Source credibility0.5
Source

Related signals

8 found